Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$307M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$294M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$246M |
| 4 |
Costco
COST
|
+$225M |
| 5 |
Lyft
LYFT
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$692M |
| 2 |
Linde
LIN
|
+$624M |
| 3 |
Medtronic
MDT
|
+$527M |
| 4 |
Goldman Sachs
GS
|
+$340M |
| 5 |
Microsoft
MSFT
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.25% |
| 2 | Healthcare | 13.3% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Sphere Entertainment
SPHR
$6.03B
| $10.2M | ﹤0.01% |
121,660
+24,243
| +25% | +$2.15M |
|
2127
The GEO Group
GEO
$4.11B
| $10.2M | ﹤0.01% |
1,434,112
-40,724
| -3% | -$256K |
|
2128
FuelCell Energy
FCEL
$1.79B
| $10.2M | ﹤0.01% |
38,201
+3,969
| +12% | +$1.16M |
|
2129
Madison Square Garden
MSGS
$9.8B
| $10.2M | ﹤0.01% |
59,068
+369
| +0.6% | +$66.7K |
|
|
BLUE
2130
DELISTED
bluebird bio
BLUE
| $10.1M | ﹤0.01% |
24,315
+7,064
| +41% | +$2.8M |
|
2131
Kforce
KFRC
$1.04B
| $10.1M | ﹤0.01% |
159,887
-2,342
| -1% | -$139K |
|
2132
iShares Global Tech ETF
IXN
$9.42B
| $10M | ﹤0.01% |
178,560
-173,436
| -49% | -$9.33M |
|
|
HNGR
2133
DELISTED
Hanger Inc.
HNGR
| $10M | ﹤0.01% |
396,911
-48,490
| -11% | -$1.21M |
|
|
SC
2134
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $10M | ﹤0.01% |
275,562
-16,956
| -6% | -$589K |
|
2135
Xtrackers Municipal Infrastructure Revenue Bond Active ETF
RVNU
$144M
| $9.99M | ﹤0.01% |
338,123
+34,167
| +11% | +$1M |
|
2136
Varex Imaging
VREX
$779M
| $9.94M | ﹤0.01% |
370,465
-44,699
| -11% | -$1.1M |
|
2137
CRISPR Therapeutics
CRSP
$5.18B
| $9.93M | ﹤0.01% |
61,306
+16,369
| +36% | +$1.99M |
|
2138
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.74B
| $9.92M | ﹤0.01% |
92,788
+1,958
| +2% | +$203K |
|
2139
Invesco Mortgage Capital
IVR
$805M
| $9.89M | ﹤0.01% |
253,702
+12,534
| +5% | +$475K |
|
|
CAI
2140
DELISTED
CAI International, Inc.
CAI
| $9.89M | ﹤0.01% |
176,527
-2,235
| -1% | -$99.2K |
|
2141
Enterprise Products Partners
EPD
$84B
| $9.87M | ﹤0.01% |
409,193
-4,665
| -1% | -$110K |
|
2142
Ameresco
AMRC
$1.48B
| $9.87M | ﹤0.01% |
157,372
-22,548
| -13% | -$1.21M |
|
2143
iShares Core MSCI Total International Stock ETF
IXUS
$60.8B
| $9.84M | ﹤0.01% |
134,235
-8,706
| -6% | -$637K |
|
2144
Artivion
AORT
$1.42B
| $9.83M | ﹤0.01% |
345,927
-48,169
| -12% | -$1.31M |
|
|
SRNE
2145
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $9.82M | ﹤0.01% |
1,013,177
+104,926
| +12% | +$836K |
|
2146
Ingles Markets
IMKTA
$1.65B
| $9.81M | ﹤0.01% |
168,403
+3,783
| +2% | +$235K |
|
2147
Option Care Health
OPCH
$3.59B
| $9.81M | ﹤0.01% |
448,514
+186,845
| +71% | +$3.6M |
|
|
CERE
2148
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $9.8M | ﹤0.01% |
382,491
-448,297
| -54% | -$6.42M |
|
2149
Coinbase
COIN
$39.2B
| $9.8M | ﹤0.01% |
+38,679
| New | +$10M |
|
2150
Vanguard Total World Stock ETF
VT
$81.8B
| $9.79M | ﹤0.01% |
94,470
-10,932
| -10% | -$1.11M |
|
Similar funds
Bank of New York Mellon's Q2 2021 Portfolio in Review
As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
- Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
- Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
- Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
- Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.
Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.